(Q43847264)

27 November 2017

title

TAT-NEP1-40 as a novel therapeutic candidate for axonal regeneration and functional recovery after stroke (English)

1 reference

27 November 2017

Xingchun Gou

1

1 reference

27 November 2017

Qiang Wang

2

1 reference

27 November 2017

Qianzi Yang

3

1 reference

27 November 2017

Lixian Xu

4

1 reference

27 November 2017

Lize Xiong

5

1 reference

27 November 2017

language of work or name

1 reference

1 April 2010

1 reference

Journal of Drug Targeting

27 November 2017

published in

1 reference

27 November 2017

volume

19

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

86-95

1 reference

PirB is a functional receptor for myelin inhibitors of axonal regeneration.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

TAT-mediated protein transduction into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Receptors for myelin inhibitors: Structures and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

The Nogo-66 receptor NgR1 is required only for the acute growth cone-collapsing but not the chronic growth-inhibitory actions of myelin inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Protein transduction technology offers novel therapeutic approach for brain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Nogo receptor antagonizes p75NTR-dependent motor neuron death.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Bioavailability and transport of peptides and peptide drugs into the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Tat-mediated delivery of heterologous proteins into cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Stroke epidemiology in the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

PirB, a second receptor for the myelin inhibitors of axonal regeneration Nogo66, MAG, and OMgp: implications for regeneration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Cellular uptake of the tat protein from human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

The impact of increased duration of exercise therapy on functional recovery following stroke--what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Nogo-66 receptor antagonist peptide promotes axonal regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

PTD-XIAP protects against cerebral ischemia by anti-apoptotic and transcriptional regulatory mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

High-level expression, polyclonal antibody preparation and sub-cellular localization analysis of mouse Rhox5 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Blockade of Nogo receptor ligands promotes functional regeneration of sensory axons after dorsal root crush.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Targeting neurite growth inhibitors to induce CNS regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

TAT fusion proteins against ischemic stroke: current status and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Tissue plasminogen activator does not benefit most eligible patients with stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Two novel mammalian Nogo receptor homologs differentially expressed in the central and peripheral nervous systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

The Nogo-66 receptor: focusing myelin inhibition of axon regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Gangliosides and Nogo receptors independently mediate myelin-associated glycoprotein inhibition of neurite outgrowth in different nerve cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Effects of the free radical scavenger, edaravone, on the development of postoperative cognitive impairment in patients undergoing carotid endarterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

The blood-brain barrier: bottleneck in brain drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Characterization of two novel proteins, NgRH1 and NgRH2, structurally and biochemically homologous to the Nogo-66 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

In vitro refolding of recombinant human free secretory component using equilibrium gradient dialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

The experience of living with stroke: a qualitative meta-synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Time Is Brain--Quantified

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

In vivo protein transduction: delivery of a biologically active protein into the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Prevention and treatment of perioperative stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Why do Nogo/Nogo-66 receptor gene knockouts result in inferior regeneration compared to treatment with neutralizing agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Inhibition of brain damage by edaravone, a free radical scavenger, can be monitored by plasma biomarkers that detect oxidative and astrocyte damage in patients with acute cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Molecular dissection of the myelin-associated glycoprotein receptor complex reveals cell type-specific mechanisms for neurite outgrowth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Nogo-A is involved in secondary axonal degeneration of thalamus in hypertensive rats with focal cortical infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

TAT-mediated protein transduction of Nogo extracellular peptide 1-40 and its biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Delayed Nogo receptor therapy improves recovery from spinal cord contusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Glial inhibition of CNS axon regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003733961

10.3109/10611861003733961

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference